Filing Details

Accession Number:
0001415889-24-012937
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-10 21:35:17
Reporting Period:
2024-05-10
Accepted Time:
2024-05-10 21:35:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1857843 Daniel Rabinowitz C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Sec. And Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-10 30,000 $19.68 234,495 No 4 M Direct
Common Stock Disposition 2024-05-10 5,997 $101.55 228,498 No 4 S Direct
Common Stock Disposition 2024-05-10 9,398 $102.91 219,100 No 4 S Direct
Common Stock Disposition 2024-05-10 4,255 $104.03 214,845 No 4 S Direct
Common Stock Disposition 2024-05-10 10,350 $108.10 204,495 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-05-10 30,000 $0.00 30,000 $19.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2029-03-21 No 4 M Direct
Footnotes
  1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.30 to $102.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.83 to $103.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.85 to $104.77 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.55 to $108.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The option shares are fully exercisable.